Crossmark

Systematic analysis of genetic and phenotypic characteristics reveals antisense oligonucleotide therapy potential for one-third of neurodevelopmental disorders

Crossref DOI link: https://doi.org/10.1186/s13073-025-01477-x

Published Online: 2025-05-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wijnant, Kim N.

Nadif Kasri, Nael

Vissers, Lisenka E.L.M.
Funding

Funding for this research was provided by:

ZonMw (10250022110002, 10250022110002, 10250022110002)

Simons Foundation Autism Research Initiative (890042)

European Union’s Horizon 2020 (779257)
License Information

Text and Data Mining valid from 2025-05-21

Version of Record valid from 2025-05-21
More Information

Article History

Received: 25 June 2024

Accepted: 22 April 2025

First Online: 21 May 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below